Drug Profile
Research programme: VAP-1 SSAO enzyme inhibitors - Acorda Therapeutics
Alternative Names: BTT-2027; VAP-1 SMI; VAP-1 SSAO enzyme inhibitor; VapillLatest Information Update: 02 Mar 2017
Price :
$50
*
At a glance
- Originator Biotie Therapies Corp.
- Class Small molecules
- Mechanism of Action AOC3 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Inflammation